Mycovia Pharmaceuticals presented data from its Phase 3, randomized, double-blind, placebo-controlled VIOLET studies, which measured the efficacy and safety of oteseconazole (VT-1161) in treating recurrent…
Amgen and AstraZeneca announced results from the phase 3 NAVIGATOR trial, demonstrating that tezepelumab reduced exacerbations and improved lung function and nasal symptoms in patients…
Apparently there is a lucrative market for DNA data for medical research as a COVID-19 testing vendor is now under investigation by a data privacy…
Novatek Pharmaceuticals announced topline results from the BOSS-Covid-19 study evaluating the efficacy and safety of oral TQ Formula in COVID-19 patients in the outpatient setting. Among…
Galmed Pharma announced results from the first 16 patients enrolled in the open-label portion of the Phase 3 ARMOR study who underwent a scheduled post-baseline…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
